Development of novel platforms for cancer immunotherapy
The IVTLab is an international and interdisciplinary laboratory promoting cutting-edge research in the field of oncoimmunology and immunotherapy using viruses as platforms to induce and/or orchestrate the tumor-specific immune response. The laboratory is well supported and funded by prestigious and internationally recognised funding agencies such as the European Research Council Consolidator grant (ERC-CoG), HiLIFE, Jane and Aatos Erkko Foundation and Business Finland.
Twitter and News
Record number of publications for IVT Lab during 2021 and also superb start for the year 2022.
Even if the pandemic has had a tremendous impact on everyday life in our lab in Helsinki we have been able to produce a record number of...
Rapid peptide discovery and ‘plug-and-play’ technology could make personalised cancer vaccines reality
The new approach could help researchers quickly identify tumour-specific antigens recognised by cytotoxic T cells, generating a powerful,...
PeptiCHIP is a novel microchip-based solution that enables rapid, accurate, user-friendly and standardized tumor...
Members of the ImmunoViroTherapy Lab
The group consists of many experts and researchers with outstanding knowledge in the field of immunovirotherapy.
One of my main priorities is promoting science to non-scientific audience and I believe that it has never been a better time then now to do...